Grifols, S.A. (NASDAQ:GRFS) Rating Lowered to Strong Sell at BidaskClub
BidaskClub downgraded shares of Grifols, S.A. (NASDAQ:GRFS) from a sell rating to a strong sell rating in a research note issued to investors on Friday.
GRFS has been the topic of a number of other reports. J P Morgan Chase & Co upgraded shares of Grifols, from a neutral rating to an overweight rating in a research report on Thursday, March 30th. HSBC Holdings plc cut shares of Grifols, from a hold rating to a reduce rating in a research report on Friday, April 7th. Bank of America Corp initiated coverage on shares of Grifols, in a research report on Thursday, April 6th. They set a buy rating on the stock. Zacks Investment Research upgraded shares of Grifols, from a hold rating to a buy rating and set a $24.00 price target on the stock in a research report on Tuesday, July 4th. Finally, Goldman Sachs Group, Inc. (The) cut shares of Grifols, from a buy rating to a neutral rating in a research report on Friday, June 30th. Two equities research analysts have rated the stock with a sell rating, two have given a hold rating and three have given a buy rating to the company. Grifols, has a consensus rating of Hold and an average target price of $24.00.
Grifols, (NASDAQ:GRFS) traded up 0.072% during midday trading on Friday, reaching $20.965. 208,412 shares of the company traded hands. Grifols, has a one year low of $14.27 and a one year high of $22.83. The stock’s 50 day moving average is $21.04 and its 200 day moving average is $19.52. The company has a market capitalization of $28.09 billion, a price-to-earnings ratio of 44.044 and a beta of 0.98.
WARNING: This piece of content was originally published by Watch List News and is the property of of Watch List News. If you are viewing this piece of content on another publication, it was illegally stolen and republished in violation of US & international trademark & copyright legislation. The original version of this piece of content can be viewed at https://www.watchlistnews.com/grifols-s-a-nasdaqgrfs-rating-lowered-to-strong-sell-at-bidaskclub/1465689.html.
Hedge funds have recently added to or reduced their stakes in the stock. AKO Capital LLP bought a new stake in Grifols, during the first quarter worth $36,979,000. Vaughan Nelson Investment Management L.P. bought a new stake in Grifols, during the second quarter worth $57,845,000. FMR LLC raised its stake in Grifols, by 52.6% in the first quarter. FMR LLC now owns 6,352,581 shares of the biotechnology company’s stock worth $119,905,000 after buying an additional 2,189,431 shares during the period. NGAM Advisors L.P. raised its stake in Grifols, by 661.8% in the second quarter. NGAM Advisors L.P. now owns 632,072 shares of the biotechnology company’s stock worth $13,356,000 after buying an additional 549,097 shares during the period. Finally, Pictet Asset Management Ltd. raised its stake in Grifols, by 7.8% in the second quarter. Pictet Asset Management Ltd. now owns 5,409,186 shares of the biotechnology company’s stock worth $116,081,000 after buying an additional 390,486 shares during the period. 22.51% of the stock is owned by hedge funds and other institutional investors.
Receive News & Ratings for Grifols S.A. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Grifols S.A. and related companies with Analyst Ratings Network's FREE daily email newsletter.